Evidence map›Paper›PMID 41801474›Full record

ArticleJournal of medical systems2026

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Mohammad Moharrami, Erin Watson, Shao Hui Huang, Sreenath Madathil, John Kim, Andrew McPartlin, Nauman H Malik, Sonica Singhal, Ezra Hahn, John Waldron and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mohammad MoharramiFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Erin WatsonFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Shao Hui HuangDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Sreenath MadathilFaculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC, Canada.
John KimDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Andrew McPartlinDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Nauman H MalikDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Sonica SinghalFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Ezra HahnDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
John WaldronDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Scott BratmanDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
John de AlmeidaDepartment of Otolaryngology-Head & Neck Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
Christopher YaoDepartment of Otolaryngology-Head & Neck Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
Andrew HopeDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Carlos QuinonezFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Michael GlogauerFaculty of Dentistry, University of Toronto, Toronto, ON, Canada.
Ali HosniDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada. ali.hosni@uhn.ca.

Funding

Canada Graduate Scholarships-Doctoral (CGS-D) from the Canadian Institute of Health Research (CIHR) 187502
6 · The paper itself

Abstract

To develop and validate predictive models for osteoradionecrosis (ORN) after head and neck radiation therapy (RT) using time-to-event data with death as the competing risk, and to quantify the degree of risk overestimation when the competing risk is ignored. In this prognostic study of patients who underwent curative RT between 2011 and 2018, with ongoing follow-up, sociodemographic, clinical, and dosimetric data were collected. The binary ORN outcome was defined by the ClinRad system (grade ≥ 1); all-cause mortality was the competing event. Fine-Gray regression (FGR), Random Survival Forests (RSF) with Gray's test splitting rule, and DeepHit were implemented using repeated nested stratified cross-validation. Feature selection and interpretation were guided by SHapley Additive exPlanations (SHAP). For comparison, non-competing risk models such as Cox proportional hazards (Cox PH) and standard RSF (S-RSF) with log-rank splitting rule were also trained. Of 2,466 patients, 183 developed ORN during follow-up, and 714 died. Three versions of each model were developed using 20, 10, and 5 features. The 10- and 5-feature RSF models performed best. Considering simplicity, the 5-feature model, which included tumor site, D10cc, smoking pack-years, periodontal condition, and dental insurance, was selected for production. At 60 months, Brier Score was 0.061 (95% CI: 0.060-0.063), Integrated Brier Score 0.038 (95% CI: 0.037-0.040), time-dependent AUC 0.776 (95% CI: 0.762-0.789), and C-index 0.772 (95% CI: 0.757-0.787). FGR closely followed, whereas DeepHit underperformed. Non-competing models, including the S-RSF, overestimated ORN risk, predicting an average 60-month cumulative incidence of 8.7% versus 6.8% with the 5-feature RSF. A parsimonious RSF model reliably estimated individualized ORN risk while avoiding overestimation from ignored competing risks. An interactive web application was developed to support clinical implementation.

Indexed as

Head and Neck NeoplasmsMachine LearningOsteoradionecrosisAgedFemaleHumansMaleMiddle AgedPredictive Learning ModelsPrognosisProportional Hazards ModelsRandom ForestRisk AssessmentRisk FactorsCompeting risksFine-gray regressionHead and neck cancerOsteoradionecrosisPredictive modelingRandom survival forests

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.